Conclusions: 57 Our results suggest that in mice, the effects of chronic exposure to DPhP, even at a low dose, are 58 not negligible. Fatty acid metabolism in the liver in particular is essential for controlling fast and 59 feast periods with adverse consequences on the overall physiology. Therefore, the impact of DPhP 60 on circulating fat, cardiovascular and metabolic disease incidence deserves, in light of our results, 61 further investigations. 62 63 3 1. Introduction 64 Di-phenyl phosphate (DPhP) has been used as a main biomarker for assessing exposure to aryl 65 phosphate esters (APEs), especially tri-phenyl phosphate (TPhP), a molecule suspected of 66 presenting human health hazards. However, this degradation compound can be produced from 67 several APEs including ethylhexyl di-phenyl phosphate (EHDPhP) or the resorcinol 68 bis(diphenyl phosphate) (RDP) 1,2 and tert-butylphenyl diphenyl phosphate (BPDP) 3 . Moreover,
Aryl phosphate esters (APEs), a main class of organophosphorus ester molecules, are widely used 27 and commonly present in the environment. Health hazards associated with these compounds 28 remain largely unknown and the effects of diphenyl phosphate (DPhP), one of their most frequent 29 derivatives in human samples, are poorly characterised. 30
Objective:
31
Our aim was to investigate whether DPhP per se may represent a more relevant marker of 32 exposure to APEs and determine its potential deleterious biological effects in chronically exposed 33 mice. 34
Methods:
35 Conventional animals (FVB mice) were acutely (intravenous or oral gavage) or chronically (0.1 36 mg.mL -1 , 1 mg.mL -1 , 10 mg.mL -1 in drink water) exposed to relevant doses of DPhP or triphenyl 37 phosphate (TPhP), one of its main precursors in the environment. Both molecules were measured 38 in blood and other relevant tissues by liquid chromatography-mass spectrometry (LC-MS). 39
Biological effects of chronic DPhP exposure were addressed through liver multi-omics analysis 40
combining mRNA extraction and sequencing to high resolution LC-MS to determine the 41 corresponding metabolic profile. Deep statistical exploration was performed to extract correlated 42 information, guiding further physiological analyses (immunohistochemistry (IHC) and animal growth 43 measurement). 44
Results:
45 Acute and chronic exposure to DPhP led to significant levels of this molecule in blood and other 46 tissues, an effect missing with TPhP. Multi-omics analysis confirmed the existence of biological 47 effects of DPhP, even at a very low dose of 0.1 mg.mL -1 in drinking water. Chemical structural 48 homology and pathway mapping demonstrated a clear reduction of the fatty-acid catabolic 49 processes centred on acylcarnitine and mitochondrial -oxidation. Interestingly, mRNA expression 50 confirmed and extended these observations by demonstrating at all tested doses the overall 51 repression of genes involved in lipid catabolic processes and regulated by PPAR, a master 52 regulator of -oxidation and its associated ketogenesis. IHC analysis confirmed the alteration of 53 these pathways by showing a specific downregulation of Hmgcs2, a kernel target gene of PPAR, 54 at all doses tested, and surprisingly, a strong reduction of the lipid droplet content only at the highest 55 dose. Overall, DPhP absorption led to weight loss, which was significant using the highest dose. 56 esterase 14 . However, more recent analyses obtained from in vitro cultured hepatocytes, revealed 89 that the main metabolites derived from TPhP were hydroxylated and glucuronated forms of 90 TPhP 15 . Importantly, these metabolites and their equivalents for EHDPhP have recently been 91 detected in human urine samples 16 , although DPhP remained the most abundant metabolite in 92 these samples. This indicates either that degradation of APEs does not primarily occur in the 93 human liver, or that APEs are rapidly degraded and absorbed as DPhP by the environment. 94 Finally, the presence of DPhP in the environment could be directly due to its importance as a 95 catalyst in polymerisation processes. 96 In line with these hypotheses, a recent study showed that serum hydrolase significantly 97 contributes to TPhP and EHDPhP clearance and production of DPhP 17 . Bacteria present in the 98 environment and the microbiota are likely to participate in this type of transformation since 99 bacterial metabolism is able to fully degrade TPhP, DPhP initially being the main metabolite 100 released in the biofilm 18 . Similarly, microsomal preparation of human skin demonstrated the 101 ability of carboxylesterases to efficiently generate DPhP from TPhP 19 , indicating that likelihood 102 of TPhP to reach subcutaneous fat and blood through this route of exposure is very low. Rapid 103 detection of DPhP in urine samples of women exposed to TPhP through nail polish tends to 104 confirm this hypothesis 20 . Finally, DPhP concentrations in the environment are strongly dose-dependently detectable in whole blood with lower concentrations measured than those 162 obtained previously ( Figure 1C ). This was expected since the dose was now spread over a much 163 longer period. Inversely, we did not detect any significant amount of TPhP in animals exposed 164 to this same molecule through drinking water (data not shown). Most importantly, DPhP was 165 not retrieved from the whole blood of animals exposed by this route to TPhP ( Figure 1D) . 166 Since the liver is the first organ to process exogenous molecules absorbed from the digestive 167 tract, we further determined if these molecules were present in this organ using the same 168 exposure doses via drinking water. DPhP was detected and quantified in a dose-dependent 169 manner at all concentrations tested ( Figure 1E ), indicating that the molecule is efficiently 170 absorbed in the liver before its eventual bio-transformation and clearance by the kidney. Again, 171 neither TPhP nor DPhP were detected in the liver of animals exposed to TPhP through drinking 172 water ( Figure 1F ), confirming that TPhP ingestion is not at the origin of the DPhP found in 173 human urine.
174
Bio-accumulation and distribution of DPhP in chronically exposed mice 175 Based on these analyses, we next focused on the consequences of chronic exposure to DPhP. 176 Mice were exposed daily to similar doses of DPhP in their drinking water, over a 12-week 177 period. We analysed four tissues, namely the whole blood, the liver, the visceral fat and the 178 mammary gland, potentially presenting a tropism for the molecule, either due to their chemical 179 characteristics (presence of hydrophobic constituent for mammary gland and visceral fat) or to 180 the route of exposure used for these experiments (whole blood and liver). In the blood, DPhP 181 was again significantly detected in all animals chronically exposed to DPhP in drinking water 182 at 1 mg/mL and 10 mg/mL. (Figure 2A ). Values obtained after chronic treatment were 183 significantly higher in comparison with our previous overnight exposure ( Figure 1E and 2A).
184
For instance, exposure to 1 mg/mL resulted in an increase (> 2-fold), indicating that a 185 cumulative effect occurred during chronic exposure. DPhP was also detected in the liver at all 186 tested concentrations in a dose-dependent manner ( Figure 2B ). However, a cumulative effect 187 was not observed here, suggesting that other tissues had likely absorbed the molecule and/or 188 released it into the bloodstream. Consistently, DPhP was detected in both visceral fat and 189 mammary gland, gradually increasing with treatment doses (Figure 2C , D).
190
Biological effects of exposure to DPhP through metabolomics analyses of the liver 191 Since DPhP was abundant in the liver of all treated animals, even at the lowest concentration 192 of 0.1 mg/L given via drinking water, we focused our subsequent experiments on this organ in 193 order to measure the possible biological consequences of these molecules. Through multiple 194 injections (n = 8), we first verified that the metabolic profiles obtained by LC-HRMS could Figure S1 ). As expected, discriminating compounds were relatively 204 heterogeneous, chemically and functionally, even though a subset of acylcarnitines were 205 apparently significantly downregulated in exposed animals at all concentrations. From these 206 first hits, we decided to perform an in-depth analysis combining 175 annotated metabolites Table 1 ). Due to the heterogeneity of these metabolites and, for some of them, 210 their non-appurtenance to the endogenous metabolism, we performed an initial comparison 211 based on their structural homology and chemical ontology. This type of analysis eliminates bias 212 due to incomplete mapping and network size heterogeneity observed when using classical 213 pathway enrichment 26 . A circular tree plot for each concentration is shown in Figure 4A . One 214 of the clusters clearly highlighted acylcarnitines, an important amount of these metabolites 215 showing a clear trend towards a lower concentration after exposure to DPhP. Interestingly, 216 another pool of increasing metabolites appeared in a dose-dependent manner, revolving around 217 the purine nucleotides and containing metabolites associated with the synthesis of nicotinamide 218 dinucleotide. To extend these analyses, we then constructed an enrichment plot displaying the 219 significance of the observed change for structural homologies, the size of the cluster and the 220 homogeneity of their variation ( Figure 4B and S2A, B). We confirmed a strong and significant 221 decrease in acylcarnitines for all DPhP concentrations. In line with these results, an important 222 number of fatty acids were altered, even though the direction of these alterations was not 223 homogeneous. Moreover, we also noted an increase in purine-relative metabolites, even for the 224 lowest DPhP concentration with a significant dose-dependent increase (cluster purine, 225 purinone, nicotinic acid). Next, to determine how these different clusters were organised around 226 endogenous metabolic networks, we combined chemical and biochemical mapping in a joint 227 analysis using the MetaMapp algorithm 27 ( Figure 4C and S2C, D). A clear connection was 228 observed between the reduction of acylcarnitine pool and the decrease in a subset of fatty acids.
229
Conversely, the increase in purine and dinucleotide metabolism was more scattered in the 230 network mapping nucleic base, and tryptophan metabolism clusters. Moreover, we noted the 231 existence of a metabolite pool containing endogenous and exogenous molecules with aromatic 232 cycles known to be controlled by xenobiotic-activated responses. We then decided to perform 233 a hierarchical clustering of our annotated metabolites associated with their detected level in 234 each condition, the aim being to combine on the same graph the results obtained with the 235 different concentrations of DPhP used. Interestingly, this analysis performed with only 175 236 metabolites clearly discriminated the 3 exposed conditions from the control, in a similar way to 237 the PCA based on the entire dataset of detected mass ( Figure 3A and 4D). Moreover, the 238 metabolic profiles described in this analysis and associated with exposed animals strongly 239 clustered together in comparison with the control, with the lowest concentration being the least Overall, these results indicate that fatty acid oxidation is disturbed upon exposure to DPhP, 253 combining a lack of fatty acid substrate such as oleate, and a reduction of enzymatic activities 254 required for acylcarnitine production from these substrates. Moreover, as shown above, 255 increasing doses of DPhP apparently disturbed the xenobiotic response and the metabolic 256 connections between the purine, the dinucleotide and the tryptophan metabolism. In order to 257 validate these conclusions, we performed a last series of analyses to confirm the most important 258 metabolites associated with this study. Retention time and fragmentation spectra of standards 259 were obtained and compared to the values obtained from the samples. Supplemental Table 2 260 recapitulates the confirmed metabolites and their mean and median concentrations obtained 261 with the different animals exposed. 263 The second part of our multi-omics analyses was then performed on another batch of 20 animals 264 treated identically. mRNA were extracted from pooled liver and analysed by next-generation 265 sequencing using 4 analytical replicates. Genes were then filtered and only those displaying a 266 mean RPKM > 0.2 in the control condition were conserved (Supplemental Table 3 ). PCA was 267 performed using the mean expression associated with the 4 experimental conditions. When the 268 first axis was considered, the three treated conditions were significantly different from the 269 control, the most discriminating treatment being associated with the intermediate concentration 270 of DPhP ( Figure 5A left panel). Interestingly, this pattern was correlated with the metabolic 271 difference observed, since this concentration had the greatest effects. We noticed that 44% of 272 the total variance was attributable to the first axis ( Figure 5A right panel), suggesting that the 273 genes with the highest Eigen values on this axis were the most relevant for the biological effects 274 of DPhP. We consequently selected the most discriminating genes (Supplemental Table 4 , 275 Eigen value > 0.3) and performed a gene ontology analysis using the String software v11. For 276 the analysis, genes were ranked according to their Eigen value for generating a functional 277 enrichment score/false discovery rate, then used to construct a volcano plot ( Figure 5B Table 5 ). The most significantly and highly depleted processes in the exposed 279 versus control conditions, were those related to lipid metabolism and more specifically to fatty 280 acid oxidation. However, we could also notice a significant inhibition of genetic response 281 associated with xenobiotic metabolism. These results were thus indicative of the existence of 282 an inhibition of these genetic programmes in exposed animals and of a relevant correlation with 283 our previous experiments analysing the metabolome of animals treated identically. Moreover, 284 when we retrieved the gene list associated with the fatty acid catabolic process, and selected 285 the most discriminating genes in our dataset (Eigen value > 0.3), we confirmed that these genes 286 encoded functional protein networks related to mitochondrial and peroxysomal fatty acid 287 oxidation with a very high confidence rate ( Figure 5C left panel). Since fatty acid oxidation is 288 strongly regulated by the PPAR transcription factor, we verified that PPAR signalling was also 289 among the significant terms associated with our ranked gene list ( Figure 5C right panel). The 290 network reconstructed from this last term demonstrated that PPAR target genes were at the 291 heart of the dysregulation process, strongly suggesting a specific alteration of this genetic 292 response critical for the control of lipid catabolism in the liver.
262

Biological effects of DPhP exposure through transcriptomic analyses of the liver
293
Next, we verified for each treatment dose that the same trends were observed by comparing 294 their RPKM values to those of the control. In this case, we directly used the calculated fold 295 change of genes with an RPKM value > 0.2. Based on an identical approach combining a 296 volcano plot and a protein network reconstruction for each analysis, we demonstrated that genes 297 related to fatty acid oxidation and lipid catabolism were inhibited in treated animals, 298 independently of the doses used ( Figure S3A -C and S4A-C, Supplementary Table 6 ). Of note, to control animals. Good separation between the replicates was obtained by using the 2 nd , the 306 4 th and the 5 th axis of the PCA ( Figure 6A ). For each principal component, we retrieved the 307 Eigen values and performed a Gene ontology analysis with these scores (Supplemental Table   308 7). Using the second axis in which C2 is the most distant from the control, this analysis 309 confirmed the existence of a repression of genes controlling fatty acid catabolism in samples 310 arising from treated animals ( Figure 6B ). Interestingly, by analysing the two other components, 311 we observed that the highest concentrations of DPhP also increased the expression of genes 312 associated with the synthesis of sterol-derived metabolites, indicating a more complex 313 alteration of lipid metabolism ( Figure 6C ). Finally, we noticed that the lowest DPhP 314 concentration increased the expression of genes related to the tryptophan and the xenobiotic 315 metabolism ( Figure 6D ). This was intriguing since tryptophan metabolites have been connected 316 to aryl metabolism and the xenobiotic receptor AHR 28,29 , whereas our metabolomics approach 317 revealed an accumulation of the same benzene derivatives in a dose-dependent manner. To 318 improve sample clustering, we then tested by OPLS-DA all possible combinations able to 319 discriminate our 4 groups of replicates, using the control replicates as negative controls. Four 320 predictive components were determined (Supplemental Table 8 ), three of which were plotted Table 8 ).
325
The network highlighted two interconnected clusters of genetic programmes repressed in a 326 dose-dependent manner by DPhP, namely the fatty acid metabolism and the xenobiotic 327 response. Inversely, one cluster was related to weakly activated functions belonging to the 328 control of mRNA processes and the acute phase response. The fatty acid cluster associated 329 highly significant programmes related to fatty acid oxidation, peroxysome and PPAR 330 transcriptional response ( Figure 6F ). Moreover, fatty acid biosynthetic processes such as fatty 331 acid elongation also contributed to this large cluster, these latter functions being inhibited by 332 DPhP treatment. Similarly, the xenobiotic cluster associated several types of xenobiotic 333 responses such as those related to the cytochrome P450, the glucuronidation through the 334 aldarate metabolism, or glutathione metabolism. Lastly, although not present directly in these 335 clusters, we confirmed here that the genetic programme controlling the metabolism of 343 Since our multi-omics analysis clearly demonstrated some abnormalities in the processes 344 related to lipid catabolism and PPAR signalling, we performed a series of 345 immunohistochemical analyses revolving around key enzymes of liver physiology, involved in 346 fatty acid catabolic processes and ketone body formation. In addition, we stained the lipid 347 droplets using Perilipin 2 staining, a protein surrounding these vesicles and correlated with their 348 abundance 30 . Furthermore, we analysed enzymes controlling the gluconeogenesis to verify that 349 an overall unspecific dysregulation of liver metabolism did not appear following DPhP 350 treatment ( Figure 7A ). Expression of Pck1 was thus not repressed by exposure to DPhP, 351 indicating the absence of a global hepatic dysregulation. In some treated animals, Pck1 352 expression even increased, a mechanism associated with fasting. Conversely, the most striking 353 difference observed was related to the inhibition of protein expression of Hmgcs2, a kernel 354 PPAR target gene, even at the lowest dose of DPhP ( Figure 7A ). This reduction occurred more 355 specifically in the peri-portal area, where Hmgcs is normally more strongly expressed and 356 active ( Figure 7B and S5A) . At the highest dose, 100% of animals presented this physiological 357 alteration. Interestingly, this lower expression of HMGCS2 was highly correlated with a 358 reduction of the amount of lipid droplets in animals exposed to 10 mg.L-1 of DPhP ( Figure 7A -359 C and S5B). However, this was not the case for the lowest doses where the amount of Perilipin 360 2 staining increased upon exposure to DPhP, indicating that lower PPAR and -oxidative 361 activities may spare some fatty acids from storage depletion in these conditions. PPAR 362 staining was also uncorrelated with Hmgcs2 expression since exposed animals displayed a 363 stronger nuclear and cytosolic expression ( Figure 7A ), indicating that an active repression of 364 its transcriptional activity was likely taking place after DPhP treatment.
Chronic DPhP treatment disturbs protein expression of the liver and the overall physiology
365
All of our results highlight the disturbance in lipid metabolism. More specifically, DPhP-treated 366 animals presented signs of fasting, including free fatty acid content and lipid droplet reduction, 367 and reduction of fatty acid biosynthesis and oxidation. We thus used our previous cohort to 368 construct the growth curve of these animals according to their overall weight gain. No 369 significant difference was observed at the lowest doses, but a trend for weight loss was clearly 370 evident in a dose-dependent manner ( Figure 7D ). Moreover, weight gain was significantly 371 lowered in animals treated with the highest dose of DPhP. we believe that experimental procedures revolving around DPhP such as those presented in this 378 study are likely more relevant for assessing APE toxicity.
379
Using this strategy, our results clearly demonstrate that DPhP, even at low doses, disturbs liver 380 metabolism, especially the lipids used in this organ. We clearly observed a reduction of the 381 main free fatty acids (C16.0, C18.0, C18.1) and even a stronger effect on the acylcarnitine pools 382 associated with the degradation of these fatty acids. In line with these results, dodecanedioic 383 acid, a metabolite associated with the impairment of mitochondrial -oxidation of fatty acids 33 384 was dose-dependently accumulated during DPhP exposure. Moreover, our results demonstrate 385 that the genetic programmes associated with the oxidation of fatty acids were strongly 386 repressed, even at the lowest DPhP exposure concentration. Finally, an impact on the liver fat 387 content and body weight of the animals could be observed, especially at the highest dose of 388 DPhP where fatty acids and sterol synthesis was apparently also disturbed in an inverted 389 manner, at least at the transcriptional level. Taken together, these results strongly point towards 390 a significant dysregulation of lipid homeostasis, likely involving PPAR activity and possibly 391 other members of this nuclear receptor family.
392
PPAR is a key coordinator of fast-fed transition at the hepatic level with paradoxical effects 34 .
393
PPAR is thus the main activator of fatty acid oxidation and ketogenesis during adaptation to 394 long-term fasting 35 , but also in normal conditions to circadian feeding 36 . Therefore, PPAR 395 controls on the one hand de novo lipid synthesis and fatty acid uptake during feeding periods, 396 supplying store droplets, and on the other hand it activates triglyceride and cholesteryl-ester 397 lysis and oxidation of released lipids between meals. The simultaneous inhibition of fatty acid 398 oxidation and reduction of the main fatty acid produced by de novo synthesis perfectly 399 corresponds to a model of PPAR inhibition upon exposure to DPhP, the lack of fatty acid 400 likely contributing to the overall reduction of acylcarnitines. Our findings that lipid stores in 401 the liver of animals exposed to low concentrations of DPhP are not depleted is also coherent 402 with this model, since an equilibrium may be found between the lack of fatty acid storage and 403 a lower use of these fatty acids. However this may have several consequences, for instance it 404 has been shown that PPAR inhibition is associated with a higher amount of plasma 405 triglyceride and LDL 37,38 , both being strongly associated with the development of 406 cardiovascular disease, dyslipidemia, metabolic syndrome and even cancer.
407
Importantly, this equilibrium is likely subtle and not easy to maintain, since we can clearly see 408 a tendency towards weight reduction in exposed animals and a reduction in lipid stores in those 409 ingesting the highest dose of DPhP. Several mechanisms could contribute to these secondary 410 effects, taking place directly in the liver or involving a more complex interaction with other 411 organs. First, despite reduction in fatty acid oxidation, this effect may not be sufficient to 412 compensate for the lack of fatty acid uptake and production at some threshold of PPAR Interestingly, our study highlights the regulation of xenobiotic and tryptophan metabolism.
422
Indeed, we noticed the alteration of several metabolites, endogenous and exogenous, containing 423 an aromatic ring and/or associated with the tryptophan metabolism. These compounds are 424 implicated in the regulation of AHR, an important xenobiotic receptor 40 . Moreover, even 425 though DPhP does not contain the classical polycyclic structure associated with known ligands 426 of these receptors, it possesses two aromatic rings susceptible to stack with these structures and 427 disturbing their interaction with AHR. Moreover at the genetic level, we also noticed that 428 exposure to DPhP disturbs the xenobiotic response and tryptophan metabolism. We verified the 429 level of AHR, and the expression of canonical target genes of this receptor but did not observe 430 any obvious difference. However, this was expected as mice were not challenged with a 431 classical AHR agonist, although it raises questions as to the possible interactions between DPhP 432 and a classical aromatic polycyclic hydrocarbon. Finally, recent studies suggest that AHR may 433 be involve in fatty acid metabolism 41 , independently of its role as a xenobiotic regulator, 434 potentially explaining part of the biological effects of DPhP.
435
In conclusion, our results raise many questions on the use, the safety and the presence in the 436 environment of APEs, most of them being susceptible to expose humans to DPhP. We did not 437 fully characterise the molecular mechanisms underlying the apparent alterations in lipid 438 homeostasis and PPAR activities by these compounds, as this was beyond the scope of our 476 A liquid solid extraction was developed for the targeted analysis of diphenyl phosphate and 477 triphenyl phosphate. 20 mg of liver were weighed and 45 µL of internal standard solution at 2 478 ppm of DPP-d10 and TPP-d15 were added. The mixture was homogenized with a vortex and 479 evaporated. Three zirconium balls, 1 mL of acetonitrile and 0.5 mL of heptane were added. The 480 mixture was homogenized again during 2 min at 3,200 rpm and centrifuged at 10,000 rpm for For the HILIC column, the mobile phase was water 5 mM ammonium formate and 0.01% 506 formic acid (A) and acetonitrile:water 95/5 (v/v) 5 mM ammonium formate and 0.01% formic 507 acid (B). The elution gradient had a flow rate of 0.4 mL/min and started with 95% of B and was 508 held for 2 min. It was then decreased to 70% in 7 min and 50 % in another 2 min. The percentage 509 was held for 4 min to return to the initial percentage in 0.1 min and equilibrated during 10 min.
Sample preparation for metabolomics
510
The total running time was 25 min. The injection volume was 5 µL.
511
The chromatographic system was coupled to a QToF mass spectrometer (Maxis Plus, Bruker 
598
The sequencing reads were obtained after demultiplexing the raw sequencing data using 599 bcl2fastq v2. 19.1.403 (Version v2.15 .0 for NextSeq™ 500 and HiSeq® X Systems, Illumina), 600 after having validated the quality controls of each sample using the FastQC v0.11.5 software 601 (https://www.bioinformatics.babraham.ac.uk/projects/fastqc/). The alignment files were 602 generated with STAR v2.5.2b (University of Birmingham) in the 2-pass mode. We used the 603 GRCm38, version M16 (Ensembl 91) as reference. This mode is known to improve the 604 detection of more reads mapping novel splice junctions. EnhanceVolcano Plot) was eventually used to represent the discriminating functions for the 617 studied axis through the enrichment score and the false discovery rate generated by the STRING 618 algorithm. Only significant functions were retrieved.
619
Alternatively, paired analyses were performed using each concentration of DPhP against the 620 vehicle. In this case, retained genes were selected through the fold change between both 621 conditions. Gene ontology analysis was then performed identically with Functional Enrichment 622 Analysis (© STRING Consortium 2019).
623
Finally, in a complementary approach, density of the protein networks associated with 624 discriminating functions and encoded by the genes selected with these different approaches 625 were measured through protein-protein association networks (© STRING Consortium 2019).
626
High number of nodes and edges indicate that large functional complexes are disturbed through 627 multiple genetic regulations induced by DPhP exposure, reinforcing the probability of that 628 function being disturbed by this condition. We used high-confidence settings to retain the 629 experimentally validated interactions. A protein-protein interaction enrichment p-value was 630 calculated against an identical number of random proteins. Functions belonging to the KEGG database were used and only those with a p.value < 0.03 634 were conserved. Metabolic pathways and carbon metabolism functions were removed due to 635 their very high coverage of the genome. The bipartite view was then selected and an auto-layout 636 was applied. Clustering between functions was then enhanced through the Force Atlas tool.
637
Clusters were then manually highlighted and default encoding of the functions through their p-638 value was converted into a continuous green-red scale. 
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The highest significant functions belonging to these terms are listed on the right panel. 
